Novyra Pharmachem share news and announcements
BSE: 519353Agricultural Food & other ProductsSmall Cap
Last close ₹8.50down ₹0.21 (2.41%)
Share price at the BSE close on 13 Oct 2026. Previous close ₹8.71.
52-week range of traded prices to 13 Oct 2026
₹6.47Low, 13 Oct 2025₹16.55High, 23 Mar 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5.38 Cr4,706th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 8 Aug 2026
- 9.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −166.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −906.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 8 Aug 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 100
Novyra Pharmachem routine notices
71 filed, newest first. Page 1 of 2.
Oct 2026
14 Oct · Routine
Sep 2026
25 Sep · Routine
Jul 2026
13 Jul · Routine
Jun 2026
26 Jun · Routine
Apr 2026
10 Apr · Routine
Mar 2026
Jan 2026
Dec 2025
24 Dec · Routine
Oct 2025
13 Oct · Routine
Sep 2025
29 Sep · Routine
Jul 2025
Jun 2025
Apr 2025
Mar 2025
31 Mar · Routine
Jan 2025
Dec 2024
30 Dec · Routine
Oct 2024
Sep 2024
27 Sep · Routine
Jul 2024
Jun 2024
28 Jun · Routine
Apr 2024
Mar 2024
Feb 2024
Jan 2024
13 Jan · Routine
Dec 2023
30 Dec · Routine
Nov 2023
Oct 2023
Sep 2023
Aug 2023
Jul 2023
Jun 2023
May 2023
Apr 2023
Mar 2023
Feb 2023
Jan 2023
Dec 2022
Nov 2022
Oct 2022
Aug 2022
Jul 2022
Jun 2022
Apr 2022